Back to Search
Start Over
Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage.
- Source :
-
JAMA network open [JAMA Netw Open] 2022 Jan 04; Vol. 5 (1), pp. e2142531. Date of Electronic Publication: 2022 Jan 04. - Publication Year :
- 2022
- Subjects :
- Adult
Aged
Aged, 80 and over
Cross-Sectional Studies
Female
Humans
Insurance Coverage
Legislation, Medical
Male
Medicare Part C
Middle Aged
Narcotic Antagonists therapeutic use
United States
Young Adult
Buprenorphine therapeutic use
COVID-19
Drug Prescriptions
Opioid-Related Disorders drug therapy
Pandemics
Practice Patterns, Physicians' legislation & jurisprudence
Telemedicine legislation & jurisprudence
Subjects
Details
- Language :
- English
- ISSN :
- 2574-3805
- Volume :
- 5
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- JAMA network open
- Publication Type :
- Academic Journal
- Accession number :
- 34989798
- Full Text :
- https://doi.org/10.1001/jamanetworkopen.2021.42531